GABRIELLI, Armando
 Distribuzione geografica
Continente #
NA - Nord America 8589
EU - Europa 4884
AS - Asia 1042
Continente sconosciuto - Info sul continente non disponibili 14
AF - Africa 3
OC - Oceania 3
SA - Sud America 2
Totale 14537
Nazione #
US - Stati Uniti d'America 8568
UA - Ucraina 1351
SE - Svezia 890
IT - Italia 765
DE - Germania 601
DK - Danimarca 464
TR - Turchia 457
IE - Irlanda 297
KR - Corea 237
FI - Finlandia 232
SG - Singapore 231
GB - Regno Unito 126
CN - Cina 91
FR - Francia 68
BE - Belgio 41
PL - Polonia 21
CA - Canada 19
EU - Europa 14
RS - Serbia 10
JP - Giappone 9
NL - Olanda 7
RU - Federazione Russa 6
VN - Vietnam 6
HK - Hong Kong 4
AU - Australia 3
CI - Costa d'Avorio 3
IR - Iran 2
MX - Messico 2
TW - Taiwan 2
AL - Albania 1
AT - Austria 1
BR - Brasile 1
CL - Cile 1
ES - Italia 1
IN - India 1
KH - Cambogia 1
PH - Filippine 1
PT - Portogallo 1
RO - Romania 1
Totale 14537
Città #
Chandler 1478
Jacksonville 1418
Fairfield 852
Wilmington 553
Ashburn 417
Woodbridge 399
Houston 365
Des Moines 348
Centro 325
Seattle 322
Lawrence 299
Princeton 299
San Mateo 298
Dublin 297
Cambridge 236
Ann Arbor 230
San Diego 116
Beijing 81
Boardman 63
Redmond 45
Brussels 38
Marche 35
London 28
Norwalk 28
Jesi 22
Porto 20
Falls Church 19
Auburn Hills 18
Ancona 15
Izmir 15
Milan 14
Helsinki 12
Castelfidardo 11
Ottawa 11
Belgrade 10
Rome 8
Bologna 7
Brescia 6
Dong Ket 6
Hanover 6
Montréal 6
Ostra 6
San Giorgio A Cremano 6
Los Angeles 5
Nürnberg 5
San Benedetto Del Tronto 5
Sassoferrato 5
Squinzano 5
Torre Annunziata 5
Amandola 4
Chiaravalle 4
Montemarciano 4
Abidjan 3
Atella 3
Brisbane 3
Camerino 3
Civitanova Marche 3
Corridonia 3
Foggia 3
Kraków 3
Leawood 3
Nanjing 3
Pagani 3
Rotella 3
Wuhan 3
Alameda 2
Ascoli Piceno 2
Bari 2
Borås 2
Casoria 2
Cerveteri 2
Chicago 2
Fabriano 2
Florence 2
Gambettola 2
Gessate 2
Montesilvano 2
Mountain View 2
Mozzate 2
Osimo 2
Palermo 2
Pesaro 2
Pescara 2
Pollenza 2
Redwood City 2
Saint Petersburg 2
Scafati 2
Taipei 2
Trento 2
Urbino 2
Vandalia 2
Acquasanta Terme 1
Alghero 1
Arezzo 1
Bollengo 1
Busso 1
Carmona 1
Cava De' Tirreni 1
Chengdu 1
Chieti 1
Totale 8930
Nome #
Multicenter validation of the DETAIL questionnaire for the screening of spondyloarthritis in patients with inflammatory bowel diseases 112
A cross-disease meta-GWAS identifies four new susceptibility loci shared between systemic sclerosis and Crohn’s disease 108
Induction of Scleroderma Fibrosis in Skin-Humanized Mice by Administration of Anti−Platelet-Derived Growth Factor Receptor Agonistic Autoantibodies 103
La terapia con immunoglobuline endovena nelle malattie autoimmuni 91
Plasma free hemoglobin and microcirculatory response to fresh or old blood transfusions in sepsis 88
Disease course in patients with systemic autoimmune diseases: insights on the safety of immunosuppression during the SARS-CoV-2 outbreak in Italy 87
Brief Report: IRF4 Newly Identified as a Common Susceptibility Locus for Systemic Sclerosis and Rheumatoid Arthritis in a Cross-Disease Meta-Analysis of Genome-Wide Association Studies 84
Epitope specificity determines pathogenicity and detectability of anti-platelet-derived growth factor receptor α autoantibodies in systemic sclerosis 83
Stimulatory autoantibodies to PDGF receptor in patients with extensive chronic graft-versus-host disease 81
Gut epithelial impairment, microbial translocation and immune system activation in inflammatory bowel disease-associated spondyloarthritis. 80
Cognitive and cerebral hemodynamic impairment in scleroderma patients 79
Certolizumab pegol for the treatment of psoriasis 77
Computed tomography assessment of evolution of interstitial lung disease in systemic sclerosis: Comparison of two scoring systems 76
Adalimumab modulates angiogenesis in psoriatic skin 75
Assessment of gastrointestinal involvement in scleroderma. 74
Piascledine modullates the production of VEGF and TIMP-1 and reduces the invasiveness of rheumatoid arthritis synoviocytes 74
Agonistic anti-PDGF receptor autoantibodies from patients with systemic sclerosis impact human pulmonary artery smooth muscle cells function in vitro 74
Cardiac involvement in polymyositis and dermatomyositis 73
Global longitudinal strain measured by speckle tracking identifies subclinical heart involvement in patients with systemic sclerosis 73
AIRE gene polymorphisms in Systemic Sclerosis associated with autoimmune thyroiditis 72
Long lasting biological effects of PDGFR agonistic auto-antibodies in scleroderma 72
Dysbiosis and zonulin upregulation alter gut epithelial and vascular barriers in patients with ankylosing spondylitis 72
The Exaggerated Collagen Expression in Gvhd-Fibroblasts Is Effectively Inhibited By Therapeutic Concentration of Nilotinib 71
Ha-Ras stabilization mediates pro-fibrotic signals in dermal fibroblasts. 70
B CELL RECEPTOR EDITING IN SCLERODERMA PATIENTS GENERATES PATHOGENIC ANTI-PDGFR AUTOANTIBODIES 70
Subcutaneous IgG in the Myositis Spectrum Disorders 70
Aseptic inflammation of prosthetic knee in a patient affected by rheumatoid arthritis 70
Clinical outcomes and feasibility of the multidisciplinary management of patients with psoriatic arthritis: two-year clinical experience of a dermo-rheumatologic clinic 70
Scleroderma. 69
A randomized controlled trial of Rituximab for the treatment of severe cryoglobulinemic vasculitis. 69
Biomarkers in Inflammatory Bowel Disease-Associated Spondyloarthritis: State of the Art and Unmet Needs 69
Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study 69
Characterization of binding and quantification of human autoantibodies to PDGFRα using a biosensor-based approach 69
c-myb proto-oncogene is expressed by quiescent fibroblasts and unlike B-myb gene does not correlate with proliferation 68
Comment on 'Where are we going in the management of interstitial lung disease in patients with systemic sclerosis?' 68
c-myb but not B-myb upregulates a1(I) and a2(I) collagen genes in fibroblasts 67
Are HLA class II and immunoglobulin constant region genes involved in the pathogenesis of mixed cryoglobulinemia type II after hepatitis c virus infection? 67
Mesenchymal stromal cells from human umbilical cord prevent the development of lung fibrosis in immunocompetent mice 67
Subcutaneous immunoglobulin in inflammatory myopathies: efficacy in different organ systems 67
Platelet-derived growth factor and reactive oxygen species (ROS) regulate Ras protein levels in primary human fibroblasts via ERK 1/2. Amplification of ROS and Ras in systemic sclerosis fibroblasts 66
The risk of non-Hodgkin's lymphoma in coeliac disease: a case-control, multicentre study 66
Reduction of bcl-2 in T-cells during immunosuppressive therapy in patients with severe juvenile onset systemic lupus erithematosus 66
Identification of a novel human DRB1*13 allele by sequence-based DRB typing. 66
Subclinical progression of systemic sclerosis-related cardiomyopathy 66
Tocilizumab in COVID-19 interstitial pneumonia 66
Successful treatment of a Caucasian case of multifocal Castleman¿s disease with TAFRO syndrome with a pathophysiology targeted therapy - a case report 65
Reduced type I collagen gene expression by skin fibroblasts of patients with systemic sclerosis after one treatment course with rituximab 65
Influence of TYK2 in systemic sclerosis susceptibility: A new locus in the IL-12 pathway 65
Erratum: Myocardial perfusion defects in scleroderma detected by contrast-enhanced cardiovascular magnetic resonance [Radiol med, DOI 10.1007/s11547-014-0419-7] 65
Decreased serum levels of the inflammaging marker miR-146a are associated with clinical response to tocilizumab in COVID-19 patients 65
Reactive oxygen species are required for maintenance and differentiation of primary lung fibroblasts in idiopathic pulmonary fibrosis 65
Detection of typical and atypical bovine spongiform encephalopathy and scrapie prion strains by prion protein motif-grafted antibodies. 65
Osservazione di una nuova mutazione puntiforme del gene p53 nel seminoma tipico del testicolo: descrizione di un caso 64
Pathogenic autoantibodies in systemic sclerosis 64
Biosensor-based Binding Assay for Platelet-Derived Growth Factor Receptor-α Autoantibodies in Human Serum 64
Microcirculatory effects of the transfusion of leukodepleted or non-leukodepleted red blood cells in patients with sepsis: a pilot study. 64
Biologics in inflammatory and immunomediated arthritis 63
The DETection of Arthritis in Inflammatory boweL diseases (DETAIL) questionnaire: development and preliminary testing of a new tool to screen patients with inflammatory bowel disease for the presence of spondyloarthritis 63
WIF1, A WNT PATHWAY INHIBITOR, IS SILENCED IN SYSTEMIC SCLEROSIS BY DNA DAMAGE: A MECHANISM LINKING DNA DAMAGE TO WNT AND FIBROSIS 62
Immunohistochemical localization of intracellular and extracellular associated TGFb in the skin of patients with systemic sclerosis (scleroderma) and primary Raynaud's phenomenon 62
Isolation of agonistic autoantibodies specific for the PDGF receptor from the B cell repertoire of SSC patients 62
Characterization of the c-Myb-responsive region and regulation of the human type I collagen α2 chain gene by c-Myb 62
Long-term outcome and prospective validation of NIH response criteria in 39 patients receiving imatinib for steroid-refractory chronic GVHD 62
A reactive Oxygen species -mediated loop mantains increased expression of NADPH oxidases 2 and 4 in skin fibroblasts from patients with systemic sclerosis 62
Regional implantation of autologous adipose tissue-derived cells induces a prompt healing of long-lasting indolent digital ulcers in patients with systemic sclerosis 62
Pleuroparenchymal fibroelastosis in systemic sclerosis: prevalence and prognostic impact 62
Dynamics of hepatitis C virus viremia after perturbation by plasma exchange 61
Raloxifene reduces urokinase-type plasminogen activator-dependent proliferation of synoviocytes from patients with rheumatoid arthritis 61
TOSSE STIZZOSA: PRESENTAZIONE ATIPICA DI UNA VASCULITE DEI GRANDI VASI 61
Demographic, clinical and antibody characteristics of patients with digital ulcers in systemic sclerosis: data from the DUO registry 61
Role of HLA class II in HCV-related disorders 60
Subcutaneous immunoglobulin in polymyositis and dermatomyositis: a novel application. 60
Ha-Ras/ERK1-2 pathway is responsable for oxygen species generation by scleroderma skin fibroblasts 60
PDGF receptor as therapeutic and diagnostic target in systemic sclerosis 60
Subcutaneous immunoglobulins in polymyositis and dermatomyositis: a novel application. 60
Systemic sclerosis (scleroderma) and cancer risk: Systematic review and meta-analysis of observational studies 60
Stimulatory autoantibodies against PDGF receptor in systemic sclerosis 59
Risk of non-Hodgkin lymphoma in celiac disease 59
SpA and PsA basic and translational research OP0205 Gut Dysbiosis in Patients with HLA-B27+ Ankylosing Spondylitis is Associated with Ileitis, Down-Regulation of Tight Junction Proteins, Increased Serum Levels of LPS and Monocytes Anergy 59
Sclerostin and Antisclerostin Antibody Serum Levels Predict the Presence of Axial Spondyloarthritis in Patients with Inflammatory Bowel Disease 59
Mapping and predicting mortality from systemic sclerosis 59
Recommendations for the management of biofilm: a consensus document. 59
Mycophenolate mofetil-induced colitis in a patient with systemic sclerosis 59
Bone marrow endothelial progenitors are defective in systemic sclerosis 58
Scleroderma fibroblasts constitutively express the long pentraxin PTX3. 58
Sarcoidosis and cancer risk: systematic review and meta-analysis of observational studies. 58
Patient Reported Outcomes and Quality of Life in a Cohort of Patients Affected by Entheropathic Spondyloarthritis: Preliminary Results from a Monocentric Prospective Observational Study 58
Where are we going in the management of interstitial lung disease in patients with systemic sclerosis? 58
Subclinical Cardiac Dysfunction in Polymyositis and Dermatomyositis: A Speckle-tracking Case-control Study 58
Adalimumab efficacy in enteropathic spondyloarthritis: A 12-mo observational multidisciplinary study 58
Vasodilators and low-dose acetylsalicylic acid are associated with a lower incidence of distinct primary myocardial disease manifestations in systemic sclerosis: results of the DeSScipher inception cohort study 58
Low-dose Oral Imatinib in the treatment of systemic sclerosis interstitial lung disease unresponsive to cyclophosphamide. A phase II pilot study 58
Effect of Adalimumab Therapy on Both Gastrointestinal and Articular Inflammation at 6 Months in Patients Affected by Enteropathic Spondyloarthritis: Preliminary Results from a Monocentric Prospective Observational Study 58
Delection of typical and atypical bovine spongiform encephalopathy and scraipe prion strains by prion protein motif-grafted antibodies 57
Scleroderma-like fibrosis in chronic graft-vs-host disease is sustained by anti-PDGF receptors antibodies 57
Traiano: Educational (but not only) opportunity for Master Students 57
BIOLOGIC THERAPY IN INFLAMMATORY AND IMMUNOMEDIATED ARTHRITIS: SAFETY PROFILE 57
A gender gap in primary and secondary heart dysfunctions in systemic sclerosis: A EUSTAR prospective study 57
Intracellular free radical production by peripheral blood T lymphocytes from patients with systemic sclerosis: Role of NADPH oxidase and ERK1/2 56
Acute myocarditis associated with adenoviral infection in a patient with scleroderma 56
Totale 6701
Categoria #
all - tutte 37520
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 37520


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2017/2018331 0000 00 00 472571413
2018/20191116 48723637 81298 7218 1811929
2019/20201791 431028014 29519 29534 2972986389
2020/20213995 19442255941 526200 374232 438342449218
2021/20222164 11954167131 20114 78164 136135206453
2022/20233980 385444348362 311739 17298 1076000
Totale 14906